Log in

LON:CRVCraven House Capital Share Price, Forecast & News

GBX 0.75
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
0.75
Now: GBX 0.75
0.75
50-Day Range
0.75
MA: GBX 1.25
1.95
52-Week Range
0.74
Now: GBX 0.75
295
VolumeN/A
Average Volume439 shs
Market Capitalization£28,976.93
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Craven House Capital plc operates as an investment company. It also focuses on investing in or acquiring a portfolio of companies, partnerships, joint ventures, businesses, or other assets in various geographical jurisdictions. The company was formerly known as AIM Investments plc and changed its name to Craven House Capital plc in August 2011. Craven House Capital plc was incorporated in 2004 and is based in London, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.67 out of 5 stars


Industry, Sector and Symbol

Industry Asset Management
Sub-IndustryN/A
CUSIPN/A
CIKN/A
Phone44 2032 868130

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£1.66 million
Cash FlowGBX 0.60 per share
Book ValueGBX 670.50 per share

Profitability

Miscellaneous

Employees4
Market Cap£28,976.93
Next Earnings DateN/A
OptionableNot Optionable

Receive CRV News and Ratings via Email

Sign-up to receive the latest news and ratings for CRV and its competitors with MarketBeat's FREE daily newsletter.

Craven House Capital (LON:CRV) Frequently Asked Questions

How has Craven House Capital's stock been impacted by COVID-19 (Coronavirus)?

Craven House Capital's stock was trading at GBX 3.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CRV shares have decreased by 80.5% and is now trading at GBX 0.75. View which stocks have been most impacted by Coronavirus.

Has Craven House Capital been receiving favorable news coverage?

News stories about CRV stock have been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Craven House Capital earned a media sentiment score of -1.3 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news about Craven House Capital.

Who are some of Craven House Capital's key competitors?

Who are Craven House Capital's key executives?

Craven House Capital's management team includes the following people:
  • Mr. Brian Winters, Company Sec. & Gen. Counsel

What is Craven House Capital's stock symbol?

Craven House Capital trades on the London Stock Exchange (LON) under the ticker symbol "CRV."

How do I buy shares of Craven House Capital?

Shares of CRV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Craven House Capital's stock price today?

One share of CRV stock can currently be purchased for approximately GBX 0.75.

How big of a company is Craven House Capital?

Craven House Capital has a market capitalization of £28,976.93 and generates £1.66 million in revenue each year. Craven House Capital employs 4 workers across the globe.

What is Craven House Capital's official website?

The official website for Craven House Capital is www.cravenhousecapital.com.

How can I contact Craven House Capital?

The company can be reached via phone at 44 2032 868130.

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.